MV

Manju Verma

Active Director Director DIN 07762232
DIN 07762232 First appointment Mar 2017 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2017
Shareholding value •••• Premium profile

About Manju Verma

Data last updated:

Manju Verma is a Director at Weslay Lifesciences Private Limited (since 2017). The company operates in Chemicals. Weslay Lifesciences Private Limited reported revenue of ₹1.20 Cr (FY 2025).

DIN 07762232
Primary Designation Director
Industry Chemicals
First Appointment 17 Mar 2017
Oldest Company Age 10 yrs
Largest company Weslay Lifesciences Private Limited · ₹1.20 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Weslay Lifesciences Private Limited U24297KA2016PTC094566
Director17 Mar 20172016₹1.20 Cr (FY 2025)Active

Board colleagues of Manju Verma

Directorship timeline

Open interactive timeline →
Weslay Lifesciences Private Limited
Premium access

Shareholding and investment profile for Manju Verma

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Manju Verma

Manju Verma currently holds 1 directorship: Weslay Lifesciences Private Limited (Director, since 17 Mar 2017, revenue ₹1.20 Cr (FY 2025)).

Manju Verma was first appointed on 17 Mar 2017 as Director at Weslay Lifesciences Private Limited.

The current boards of Manju Verma's companies include Kolathuru Puttaswamy Pramod Kumar (Weslay Lifesciences Private Limited), Venkatesh Aishwarya (Weslay Lifesciences Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available